ID   NCOR2_MOUSE             Reviewed;        2472 AA.
AC   Q9WU42; E9Q9V0; Q9WU43; Q9WUC1;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   07-APR-2021, entry version 188.
DE   RecName: Full=Nuclear receptor corepressor 2;
DE            Short=N-CoR2;
DE   AltName: Full=Silencing mediator of retinoic acid and thyroid hormone receptor;
DE            Short=SMRT;
DE            Short=SMRTe;
DE   AltName: Full=T3 receptor-associating factor;
DE            Short=TRAC;
DE   AltName: Full=Thyroid-, retinoic-acid-receptor-associated corepressor;
GN   Name=Ncor2; Synonyms=Smrt;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA).
RC   TISSUE=Brain, and Spleen;
RX   PubMed=10077563; DOI=10.1073/pnas.96.6.2639;
RA   Ordentlich P., Downes M., Xie W., Genin A., Spinner N.B., Evans R.M.;
RT   "Unique forms of human and mouse nuclear receptor corepressor SMRT.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2639-2644(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA).
RC   TISSUE=Embryo;
RX   PubMed=10097068; DOI=10.1073/pnas.96.7.3519;
RA   Park E.J., Schroen D.J., Yang M., Li H., Li L., Chen J.D.;
RT   "SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-
RT   extended isoform that is more related to the nuclear receptor
RT   corepressor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:3519-3524(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   INTERACTION WITH C1D.
RX   PubMed=9405624; DOI=10.1073/pnas.94.26.14400;
RA   Zamir I., Dawson J., Lavinsky R.M., Glass C.K., Rosenfeld M.G., Lazar M.A.;
RT   "Cloning and characterization of a corepressor and potential component of
RT   the nuclear hormone receptor repression complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14400-14405(1997).
RN   [5]
RP   INTERACTION WITH HDAC7.
RX   PubMed=10640276;
RA   Kao H.-Y., Downes M., Ordentlich P., Evans R.M.;
RT   "Isolation of a novel histone deacetylase reveals that class I and class II
RT   deacetylases promote SMRT-mediated repression.";
RL   Genes Dev. 14:55-66(2000).
RN   [6]
RP   INTERACTION WITH CBFA2T3.
RX   PubMed=11533236; DOI=10.1128/mcb.21.19.6470-6483.2001;
RA   Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N.,
RA   Downing J.R., Meyers S., Hiebert S.W.;
RT   "ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with
RT   multiple histone deacetylases and binds mSin3A through its oligomerization
RT   domain.";
RL   Mol. Cell. Biol. 21:6470-6483(2001).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-550 AND SER-2215, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH NR4A2.
RX   PubMed=19144721; DOI=10.1242/dev.029769;
RA   Jacobs F.M., van Erp S., van der Linden A.J., von Oerthel L., Burbach J.P.,
RA   Smidt M.P.;
RT   "Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation
RT   through release of SMRT-mediated repression.";
RL   Development 136:531-540(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2181, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149; SER-152; THR-549;
RP   SER-550; SER-747; SER-750; THR-1350; SER-1565; SER-1749; SER-2004;
RP   SER-2012; SER-2015; SER-2016; SER-2018; THR-2020; SER-2181 AND SER-2215,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1983, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [12]
RP   INTERACTION WITH MECP2.
RX   PubMed=23770565; DOI=10.1038/nn.3434;
RA   Lyst M.J., Ekiert R., Ebert D.H., Merusi C., Nowak J., Selfridge J.,
RA   Guy J., Kastan N.R., Robinson N.D., de Lima Alves F., Rappsilber J.,
RA   Greenberg M.E., Bird A.;
RT   "Rett syndrome mutations abolish the interaction of MeCP2 with the
RT   NCoR/SMRT co-repressor.";
RL   Nat. Neurosci. 16:898-902(2013).
RN   [13]
RP   DNA-BINDING, AND INTERACTION WITH BCL6.
RX   PubMed=23455674; DOI=10.1038/ni.2543;
RA   Huang C., Hatzi K., Melnick A.;
RT   "Lineage-specific functions of Bcl-6 in immunity and inflammation are
RT   mediated by distinct biochemical mechanisms.";
RL   Nat. Immunol. 14:380-388(2013).
RN   [14]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-18 AND ARG-1854, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Transcriptional corepressor. Mediates the transcriptional
CC       repression activity of some nuclear receptors by promoting chromatin
CC       condensation, thus preventing access of the basal transcription.
CC       Isoform 1 and isoform 5 have different affinities for different nuclear
CC       receptors. Involved in the regulation BCL6-dependent of the germinal
CC       center (GC) reactions, mainly through the control of the GC B-cells
CC       proliferation and survival. Recruited by ZBTB7A to the androgen
CC       response elements/ARE on target genes, negatively regulates androgen
CC       receptor signaling and androgen-induced cell proliferation.
CC       {ECO:0000250|UniProtKB:Q9Y618, ECO:0000269|PubMed:19144721}.
CC   -!- SUBUNIT: Forms a large corepressor complex that contains SIN3A/B and
CC       histone deacetylases HDAC1 and HDAC2. This complex associates with the
CC       thyroid (TR) and the retinoid acid receptors (RAR) in the absence of
CC       ligand, and may stabilize their interaction with TFIIB. Interacts
CC       directly with RARA in the absence of ligand; the interaction represses
CC       RARA activity. Interacts (isoform SMRT) with HDAC10. Interacts with
CC       MINT. Component of the N-Cor repressor complex, at least composed of
CC       NCOR1, NCOR2, HDAC3, TBL1X, TBL1R, CORO2A and GPS2. Interacts with
CC       CBFA2T3 and ATXN1L. Interacts with RARB; the interaction is weak and
CC       does not repress RARB transactivational activity. Interacts with HDAC7
CC       and C1D. Interacts with NR4A2; this interaction increases in the
CC       absence of PITX3. Interacts with BCL6 (via the BTB domain), required
CC       for BCL6 transcriptional repressor activity on a subset of target
CC       genes. Forms ternary complexes with BCOR and BCL6 on target gene
CC       promoters but, on enhancer elements, interacts with BCL6 and HDAC3 to
CC       repress proximal gene expression. May interact with DEAF1. Interacts
CC       with RXRA. Interacts with MECP2. Interacts with ZBTB7A (By similarity).
CC       Interacts with AR (By similarity). Interacts with TBL1Y (By
CC       similarity). {ECO:0000250|UniProtKB:Q9Y618,
CC       ECO:0000269|PubMed:10640276, ECO:0000269|PubMed:11533236,
CC       ECO:0000269|PubMed:19144721, ECO:0000269|PubMed:23455674,
CC       ECO:0000269|PubMed:23770565, ECO:0000269|PubMed:9405624}.
CC   -!- INTERACTION:
CC       Q9WU42; P51608: MECP2; Xeno; NbExp=4; IntAct=EBI-6673326, EBI-1189067;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha;
CC         IsoId=Q9WU42-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=Q9WU42-2; Sequence=VSP_003414;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Also widely expressed in early embryos.
CC   -!- DOMAIN: The N-terminal region contains repression functions that are
CC       divided into three independent repression domains (RD1, RD2 and RD3).
CC       The C-terminal region contains the nuclear receptor-interacting domains
CC       that are divided in two separate interaction domains (ID1 and ID2).
CC   -!- DOMAIN: The two interaction domains (ID) contain a conserved sequence
CC       referred to as the CORNR box. This motif is required and sufficient to
CC       permit binding to unligated TR and RARS. Sequences flanking the CORNR
CC       box determine nuclear hormone receptor specificity.
CC   -!- SIMILARITY: Belongs to the N-CoR nuclear receptor corepressors family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF113001; AAD20944.1; -; mRNA.
DR   EMBL; AF113002; AAD20945.1; -; mRNA.
DR   EMBL; AF125671; AAD22972.1; -; mRNA.
DR   EMBL; AC132118; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139377; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS57382.1; -. [Q9WU42-2]
DR   RefSeq; NP_001240833.1; NM_001253904.1.
DR   RefSeq; NP_001240834.1; NM_001253905.1. [Q9WU42-2]
DR   RefSeq; XP_011239133.1; XM_011240831.2. [Q9WU42-1]
DR   BMRB; Q9WU42; -.
DR   SMR; Q9WU42; -.
DR   BioGRID; 203350; 22.
DR   CORUM; Q9WU42; -.
DR   DIP; DIP-42595N; -.
DR   IntAct; Q9WU42; 8.
DR   MINT; Q9WU42; -.
DR   STRING; 10090.ENSMUSP00000107033; -.
DR   iPTMnet; Q9WU42; -.
DR   PhosphoSitePlus; Q9WU42; -.
DR   EPD; Q9WU42; -.
DR   jPOST; Q9WU42; -.
DR   PaxDb; Q9WU42; -.
DR   PeptideAtlas; Q9WU42; -.
DR   PRIDE; Q9WU42; -.
DR   ProteomicsDB; 252659; -. [Q9WU42-1]
DR   ProteomicsDB; 252660; -. [Q9WU42-2]
DR   Antibodypedia; 1103; 267 antibodies.
DR   Ensembl; ENSMUST00000111394; ENSMUSP00000107025; ENSMUSG00000029478. [Q9WU42-2]
DR   Ensembl; ENSMUST00000111398; ENSMUSP00000107029; ENSMUSG00000029478. [Q9WU42-1]
DR   GeneID; 20602; -.
DR   KEGG; mmu:20602; -.
DR   UCSC; uc008zra.2; mouse. [Q9WU42-2]
DR   CTD; 9612; -.
DR   MGI; MGI:1337080; Ncor2.
DR   eggNOG; KOG1878; Eukaryota.
DR   GeneTree; ENSGT00940000159022; -.
DR   InParanoid; Q9WU42; -.
DR   OMA; EPGRSIH; -.
DR   OrthoDB; 12227at2759; -.
DR   Reactome; R-MMU-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-MMU-3214815; HDACs deacetylate histones.
DR   Reactome; R-MMU-350054; Notch-HLH transcription pathway.
DR   Reactome; R-MMU-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-MMU-400206; Regulation of lipid metabolism by PPARalpha.
DR   Reactome; R-MMU-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   Reactome; R-MMU-9623433; NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis.
DR   BioGRID-ORCS; 20602; 7 hits in 54 CRISPR screens.
DR   ChiTaRS; Ncor2; mouse.
DR   PRO; PR:Q9WU42; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; Q9WU42; protein.
DR   Bgee; ENSMUSG00000029478; Expressed in primary visual cortex and 308 other tissues.
DR   Genevisible; Q9WU42; MM.
DR   GO; GO:0000785; C:chromatin; ISO:MGI.
DR   GO; GO:0000118; C:histone deacetylase complex; IDA:MGI.
DR   GO; GO:0016604; C:nuclear body; IDA:MGI.
DR   GO; GO:0016363; C:nuclear matrix; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0017053; C:transcription repressor complex; ISO:MGI.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0035259; F:glucocorticoid receptor binding; ISO:MGI.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:MGI.
DR   GO; GO:0005112; F:Notch binding; ISO:MGI.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; IBA:GO_Central.
DR   GO; GO:0016922; F:nuclear receptor binding; ISO:MGI.
DR   GO; GO:0047485; F:protein N-terminus binding; ISO:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0042974; F:retinoic acid receptor binding; ISO:MGI.
DR   GO; GO:0046965; F:retinoid X receptor binding; ISO:MGI.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0021846; P:cell proliferation in forebrain; IMP:MGI.
DR   GO; GO:0030900; P:forebrain development; IMP:MGI.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:MGI.
DR   GO; GO:0003007; P:heart morphogenesis; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0060766; P:negative regulation of androgen receptor signaling pathway; ISO:MGI.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; IMP:MGI.
DR   GO; GO:1903799; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; ISO:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0090312; P:positive regulation of protein deacetylation; IDA:MGI.
DR   GO; GO:0010565; P:regulation of cellular ketone metabolic process; ISO:MGI.
DR   GO; GO:0021537; P:telencephalon development; IMP:MGI.
DR   GO; GO:0060509; P:type I pneumocyte differentiation; IMP:MGI.
DR   GO; GO:0050872; P:white fat cell differentiation; IMP:MGI.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR031557; N-CoR_GPS2_interact.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR017884; SANT_dom.
DR   Pfam; PF15784; GPS2_interact; 1.
DR   Pfam; PF00249; Myb_DNA-binding; 1.
DR   SMART; SM00717; SANT; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS51293; SANT; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coiled coil; DNA-binding; Methylation;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..2472
FT                   /note="Nuclear receptor corepressor 2"
FT                   /id="PRO_0000055623"
FT   DOMAIN          427..478
FT                   /note="SANT 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00624"
FT   DOMAIN          606..657
FT                   /note="SANT 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00624"
FT   REGION          254..312
FT                   /note="Interaction with SIN3A/B"
FT                   /evidence="ECO:0000250"
FT   REGION          2086..2090
FT                   /note="Required for interaction with RARA in the absence of
FT                   its ligand"
FT                   /evidence="ECO:0000250"
FT   COILED          165..207
FT                   /evidence="ECO:0000255"
FT   COILED          492..560
FT                   /evidence="ECO:0000255"
FT   COILED          658..682
FT                   /evidence="ECO:0000255"
FT   MOTIF           2094..2098
FT                   /note="CORNR box of ID1"
FT   MOTIF           2296..2300
FT                   /note="CORNR box of ID2"
FT   COMPBIAS        494..507
FT                   /note="Poly-Gln"
FT   COMPBIAS        775..804
FT                   /note="Pro-rich"
FT   COMPBIAS        989..999
FT                   /note="Pro-rich"
FT   COMPBIAS        1351..1357
FT                   /note="Pro-rich"
FT   COMPBIAS        1615..1619
FT                   /note="Poly-Ala"
FT   COMPBIAS        2434..2437
FT                   /note="Poly-Pro"
FT   MOD_RES         18
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         54
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         215
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         549
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         550
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         747
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         750
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         878
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         938
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         945
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         955
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         958
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1181
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1209
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1350
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1449
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1509
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1565
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1624
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1746
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1749
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1819
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1854
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         1920
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1963
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         1983
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         2004
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2012
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2015
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2016
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2018
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2020
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2035
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         2161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   MOD_RES         2181
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19144319,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         2215
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         2371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y618"
FT   VAR_SEQ         36..254
FT                   /note="Missing (in isoform Beta)"
FT                   /evidence="ECO:0000303|PubMed:10077563"
FT                   /id="VSP_003414"
FT   CONFLICT        176
FT                   /note="M -> RL (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        396..402
FT                   /note="PPMLYDA -> RHVVRR (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        555
FT                   /note="D -> H (in Ref. 1; AAD20944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        756
FT                   /note="T -> M (in Ref. 1; AAD20944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        785
FT                   /note="V -> A (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        806..846
FT                   /note="PSPAAPPATVDKDEQEAPAAPAPQTEDAKEQKSEAEEIDVG -> HHLPHPR
FT                   LLWTRMNKKPRLLQLPRQRMPRSRSLRPRRSMWE (in Ref. 1; AAD20944/
FT                   AAD20945)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        856
FT                   /note="E -> K (in Ref. 1; AAD20945)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        859
FT                   /note="E -> K (in Ref. 1; AAD20945)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        867
FT                   /note="E -> K (in Ref. 1; AAD20945)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        895
FT                   /note="E -> K (in Ref. 1; AAD20945)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        916
FT                   /note="S -> F (in Ref. 1; AAD20944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        975
FT                   /note="I -> IQ (in Ref. 1; AAD20944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1046..1063
FT                   /note="PKLPTEPPRWSSGLPFPI -> QSYRLSPHAGHRLPSH (in Ref. 2;
FT                   AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1073..1080
FT                   /note="PHAADPSA -> TRADPL (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1133
FT                   /note="Missing (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1149
FT                   /note="Missing (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1157
FT                   /note="G -> E (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1172..1201
FT                   /note="GSATSGSITKGLPSTRAADGPSYRGSITHG -> APPPVEASPRASQYPGCR
FT                   RPQLQRLYHPR (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1696
FT                   /note="A -> S (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1855..1857
FT                   /note="Missing (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1909
FT                   /note="P -> A (in Ref. 1; AAD20944/AAD20945)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1913
FT                   /note="A -> G (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1923
FT                   /note="A -> G (in Ref. 1; AAD20944/AAD20945)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1956
FT                   /note="N -> S (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1968
FT                   /note="A -> G (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2195..2196
FT                   /note="TA -> AV (in Ref. 2; AAD22972)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2213..2214
FT                   /note="SK -> LE (in Ref. 1; AAD20944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2224
FT                   /note="A -> T (in Ref. 1; AAD20944)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2472 AA;  269807 MW;  8068020DF0AAB9B7 CRC64;
     MSGSTQPVAQ TWRAAEPRYP PHGISYPVQI ARSHTDVGLL EYQHHPRDYT SHLSPGSIIQ
     PQRRRPSLLS EFQPGSERSQ ELHLRPESRT FLPELGKPDI EFTESKRPRL ELLPDTLLRP
     SPLLATGQPS GSEDLTKDRS LAGKLEPVSP PSPPHADPEL ELAPSRLSKE ELIQNMDRVD
     REITMVEQQI SKLKKKQQQL EEEAAKPPEP EKPVSPPPIE SKHRSLVQII YDENRKKAEA
     AHRILEGLGP QVELPLYNQP SDTRQYHENI KINQAMRKKL ILYFKRRNHA RKQWEQRFCQ
     RYDQLMEAWE KKVERIENNP RRRAKESKVR EYYEKQFPEI RKQRELQERM QSRVGQRGSG
     LSMSAARSEH EVSEIIDGLS EQENLEKQMR QLAVIPPMLY DADQQRIKFI NMNGLMDDPM
     KVYKDRQVTN MWSEQERDTF REKFMQHPKN FGLIASFLER KTVAECVLYY YLTKKNENYK
     SLVRRSYRRR GKSQQQQQQQ QQQQQQQMAR SSQEEKEEKE KEKEADKEEE KQDAENEKEE
     LSKEKTDDTS GEDNDEKEAV ASKGRKTANS QGRRKGRITR SMANEANHEE TATPQQSSEL
     ASMEMNESSR WTEEEMETAK KGLLEHGRNW SAIARMVGSK TVSQCKNFYF NYKKRQNLDE
     ILQQHKLKME KERNARRKKK KTPAAASEET AFPPAAEDEE MEASGASANE EELAEEAEAS
     QASGNEVPRV GECSGPAAVN NSSDTESVPS PRSEATKDTG PKPTGTEALP AATQPPVPPP
     EEPAVAPAEP SPVPDASGPP SPEPSPSPAA PPATVDKDEQ EAPAAPAPQT EDAKEQKSEA
     EEIDVGKPEE PEASEEPPES VKSDHKEETE EEPEDKAKGT EAIETVSEAP LKVEEAGSKA
     AVTKGSSSGA TQDSDSSATC SADEVDEPEG GDKGRLLSPR PSLLTPAGDP RASTSPQKPL
     DLKQLKQRAA AIPPIVTKVH EPPREDTVPP KPVPPVPPPT QHLQPEGDVS QQSGGSPRGK
     SRSPVPPAEK EAEKPAFFPA FPTEGPKLPT EPPRWSSGLP FPIPPREVIK TSPHAADPSA
     FSYTPPGHPL PLGLHDSARP VLPRPPISNP PPLISSAKHP GVLERQLGAI SQQGMSVQLR
     VPHSEHAKAP MGPLTMGLPL AVDPKKLGTA LGSATSGSIT KGLPSTRAAD GPSYRGSITH
     GTPADVLYKG TISRIVGEDS PSRLDRARED TLPKGHVIYE GKKGHVLSYE GGMSVSQCSK
     EDGRSSSGPP HETAAPKRTY DMMEGRVGRT VTSASIEGLM GRAIPEQHSP HLKEQHHIRG
     SITQGIPRSY VEAQEDYLRR EAKLLKREGT PPPPPPPRDL TETYKPRPLD PLGPLKLKPT
     HEGVVATVKE AGRSIHEIPR EELRRTPELP LAPRPLKEGS ITQGTPLKYD SGAPSTGTKK
     HDVRSIIGSP GRPFPALHPL DIMADARALE RACYEESLKS RSGTSSGAGG SITRGAPVVV
     PELGKPRQSP LTYEDHGAPF TSHLPRGSPV TTREPTPRLQ EGSLLSSKAS QDRKLTSTPR
     EIAKSPHSTV PEHHPHPISP YEHLLRGVTG VDLYRGHIPL AFDPTSIPRG IPLEAAAAAY
     YLPRHLAPSP TYPHLYPPYL IRGYPDTAAL ENRQTIINDY ITSQQMHHNA ASAMAQRADM
     LRGLSPRESS LALNYAAGPR GIIDLSQVPH LPVLVPPTPG TPATAIDRLA YLPTAPPPFS
     SRHSSSPLSP GGPTHLAKPT ATSSSERERE RERERDKSIL TSTTTVEHAP IWRPGTEQSS
     GAGGSSRPAS HTHQHSPISP RTQDALQQRP SVLHNTSMKG VVTSVEPGTP TVLRWARSTS
     TSSPVRPAAT FPPATHCPLG GTLEGVYPTL MEPVLLPKET SRVARPERPR VDAGHAFLTK
     PPAREPASSP SKSSEPRSLA PPSSSHTAIA RTPAKNLAPH HASPDPPAPT SASDLHREKT
     QSKPFSIQEL ELRSLGYHSG AGYSPDGVEP ISPVSSPSLT HDKGLSKPLE ELEKSHLEGE
     LRHKQPGPMK LSAEAAHLPH LRPLPESQPS SSPLLQTAPG IKGHQRVVTL AQHISEVITQ
     DYTRHHPQQL SGPLPAPLYS FPGASCPVLD LRRPPSDLYL PPPDHGTPAR GSPHSEGGKR
     SPEPSKTSVL GSSEDAIEPV SPPEGMTEPG HARSTAYPLL YRDGEQGEPR MGSKSPGNTS
     QPPAFFSKLT ESNSAMVKSK KQEINKKLNT HNRNEPEYNI GQPGTEIFNM PAITGAGLMT
     CRSQAVQEHA STNMGLEAII RKALMGKYDQ WEEPPPLGAN AFNPLNASAS LPAAAMPITT
     ADGRSDHALT SPGGGGKAKV SGRPSSRKAK SPAPGLASGD RPPSVSSVHS EGDCNRRTPL
     TNRVWEDRPS SAGSTPFPYN PLIMRLQAGV MASPPPPGLA AGSGPLAGPH HAWDEEPKPL
     LCSQYETLSD SE
//
